Weedstocks Newswire Feed
TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC, OTCQX:EMMBF) ("Emblem" or the "Company") delivers strategic vision to shareholders:
With adult-use legalization only days away, I am incredibly excited to provide an update on Emblem’s progress and plans for the future.
2018 has been a year of enormous change and evolution for the Emblem group of companies. We have made incredible strides and I couldn’t be prouder of the team we’ve assembled. Emblem continues to bring innovative products to market, most recently with the launch of Atmosphere oral sprays, and we’re firmly executing on our three-year strategy.
Most notably, in the third quarter we executed a strategic pivot in our approach to cannabis production, cancelling our capital-intensive production plans, and instead electing to take advantage of the significant wholesale supply capacity coming online industry-wide. This decision positions Emblem to benefit from what we expect to be falling prices in the production segment as commoditization increases. In practical terms this gives Emblem access to ample capacity, while freeing up our capital resources to focus on our passion for innovative value-added products where we already realize higher margin profiles.
Some of my proudest highlights from the past 10 months:
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
BRANTFORD, ON, Oct. 12, 2018 /CNW/ - 2599708 Ontario Inc. ("Good & Green") is pleased to announce that its wholly owned subsidiary, 2599760 Ontario Corp., received its Access to Cannabis for Medical Purposes Regulations ("ACMPR") cultivation license from Health Canada.
With this license, Good & Green is permitted to begin cultivating cannabis at its 46,000 sq. ft. indoor facility, located on five acres of land in Brantford, Ontario.
"We are proud to have achieved this important milestone. Good & Green has done a tremendous job of expeditiously progressing through Health Canada's licensing process and we look forward to supplying high quality, consistent, and homogenous organic cannabis and cannabis products", said Jeannette VanderMarel, co-founder and President of Good & Green.
"This significant achievement positions the company to be a meaningful supplier to legal medical and recreational markets, in Canada and around the world. We are looking forward to continuing to expand our community of strategic partnerships to build out best in class capabilities and deliver innovative and in demand products", said Daniel Goldberg, co-founder and Chief Executive Officer of Good & Green.
TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) today announced that it opened its new Health for Life dispensary in Baltimore, Maryland which is located at 6807 Rolling Mill Rd Baltimore, Maryland 21224. The dispensay is operated by MPX’s indirect wholly-owned subsidiary, S8 Management LLC, through its management agreement with GreenMart of Maryland, LLC (“GreenMart MD”), which is authorized to operate and sell medical cannabis products in Maryland. This is the Company’s second dispensary in Maryland, following the opening of its flagship Health for Life dispensary in Bethesda, in August 2018. Health for Life Baltimore is open to patients Sunday through Saturday. Operating hours can be found in the Health for Life website.
The dispensary, which follows MPX’s southwest dispensary staples of copper accents, rustic wood paneling and navy blue walls, is set to welcome upwards of 100 patients during opening week, with trained consultants readily available to advise on all things cannabis. Maryland residents, who are approved medical cannabis patients, will have access to flower, topicals, concentrates and other forms permitted under Maryland regulations.
“The Baltimore community is no stranger to the plant, but now seeks holistic, individualized health care,” said Julie Winter, Senior Vice President of East Coast Operations, MPX. “The array of products and services offered by the Health for Life brand makes the store more than just a medical cannabis dispensary, but rather a reliable brand that patients can go to for consistent medicine and education about the plant as it becomes mainstream.”
The Health for Life dispensary is located in a high-traffic area of Baltimore, Maryland, situated off of North Point Road in the community of Colgate. Within 2 miles of the location sits Johns Hopkins Bayview Medical Center, a teaching hospital within the world renowned John Hopkins Health System. GreenMart MD and MPX’s ‘Health for Life’ dispensary are welcomed and supported by the community leaders of Colgate.
About MPX Bioceutical Corporation
Scythian’s Chief Medical Officer, The Famed Dr. Barnes, Receives National Praise for His Advocacy, Education and Tireless Leadership from Government, Media and Medical Organizations to Assist in Making This Major Event Happen
TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) applauds the United Kingdom’s decision to allow specialist doctors the option to legally issue prescriptions for cannabis-based medicines when they believe patients could benefit from the treatment. Specialist doctors in England, Wales and Scotland will be able to prescribe cannabis-derived medicines in less than a month.
The law change, passed in Parliament yesterday, came after Home Secretary Sajid Javid listened to concerns from parents of children with conditions such as severe epilepsy. Over the summer an urgent review of cannabis-based medicinal products was called following an outcry over two young epilepsy sufferers, Alfie Dingley and Billy Caldwell, being denied access to cannabis oil.
“Congratulations to the UK Government and Home Secretary Sajid Javid, and a special congratulations to our own Chief Medical Officer, Michael Barnes, whose years of work, collaborative efforts with members of government and insatiable dedication to legalizing medicinal cannabis use helped make this decision occur,” said CEO Brady Cobb. “Scythian is proud to have you as a senior leader of our team and strongly supports your ongoing initiatives.”
Professor Michael Barnes, a leading world authority in neurological rehabilitation and an influential leader in the medical cannabis sector, has been a powerful advocate for the medical use of cannabis in the United Kingdom. Through strategic relationships and key organizations such as endourpain.org, the United Patients Alliance and Clear, as well as his participation in the drug policy innovation hub Volteface, Professor Barns has helped facilitate the accomplishment of key milestones along the UK’s path to legalizing cannabis-derived medicines. One such milestone was reached this past July when Alfie Dingley became the first person in the UK to receive a long-term licence to be treated with medicinal cannabis.
Federal Government Plain Packaging Regulations Completely Disregard Consumers and Limit Product Choice
TORONTO, Oct. 12, 2018 /CNW Telbec/ - The Federal Government of Canada is enacting strict branding and packaging restrictions on the legal cannabis market. More specifically, Health Canada has taken the framework of plain packaging tobacco products including cigarettes and cigars, and applied many aspects of that legislation to how legal cannabis products must appear. This mandate from Health Canada limits consumer choice, according to the Consumer Choice Center, and more importantly, prevents consumers from selecting products based on their personal choice.
Speaking at news conference yesterday held in the Centre Block on Parliament Hill, David Clement, North American Affairs Manager for the Consumer Choice Center (CCC) said the Federal Government seems committed to treating adult consumers like children. The branding restrictions placed on tobacco products, and now cannabis products, shows a disturbing trend of paternalism creeping further into the lives of adult consumers. It's a dangerous precedent and raises the question of what products will be targeted next.
"What we've seen is that Health Canada and our federal government are regulating products with complete disregard for consumers, and complete disregard for a continuum of risk. Our worry now is what started with tobacco has moved to cannabis, and now will move to other products, such as soft drinks, alcohol and various other food items," said David Clement, Toronto-based North American Affairs Manager for the Consumer Choice Center (CCC).
CCC has launched the Smokers Vote initiative where consumers of cannabis, tobacco products and cigars can raise their concerns about plain packaging regulations directly with their elected representatives and engage in direct democracy.
About the Consumer Choice Center
Emblem supply to reach four key provinces
TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) (“Emblem” or the "Company") today announced that its wholly-owned subsidiary, Emblem Cannabis Corporation, one of Canada’s leading licensed producers of medical cannabis, has received approval to supply British Columbia and Saskatchewan with premium cannabis products under Emblem’s adult-use brand, Symbl.
In B.C., Emblem has been approved to supply cannabis to the BC Liquor Distribution Branch (“BCLDB”) – the sole, wholesale distributor of non-medical cannabis for the province that will operate standalone, public retail stores and provide online sales. In Saskatchewan, Emblem has been approved by the Saskatchewan Liquor and Gaming Authority (“SLGA”) to supply cannabis to the province’s private retail market. A curated range of Symbl-branded dried flower strains and premium cannabis oils are expected to be available in both provinces over the coming months.
“B.C. and Saskatchewan are important markets for Emblem’s continued domestic growth plans and we look forward to working with each province as a trusted partner to supply consumers with high-quality cannabis products that will meet their needs now and into the future,” said Nick Dean, CEO, Emblem Corp. “Emblem is focused on building a business for the long-term through product innovation, developing strong brands and enhanced distribution. With supply approvals in place across four key provinces – which also includes Ontario and Alberta – we continue to expand Emblem’s footprint and open up additional markets for our brands and products.”
“Leveraging Emblem’s existing strength in the medical market, we’re excited to introduce consumers in B.C. and Saskatchewan of legal age to Symbl. Symbl was created to offer a thoughtful brand experience for those seeking cannabis for recreational use that fits within a balanced lifestyle,” said Maria Guest, CMO, Emblem Corp. “Symbl is the first of several brands that Emblem intends to create to target a number of diverse consumer segments. As Canadians begin to navigate the new cannabis landscape, we believe that Symbl will become an established source for product information and cannabis education. We look forward to working with both provinces to build the foundation for a safe and responsible marketplace for consumers.”
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./
VANCOUVER, Oct. 12, 2018 /CNW/ - Sunniva Inc. ("Sunniva" or the "Company") (CSE: SNN) (OTCQX: SNNVF) is pleased to announce that it has completed its bought deal public offering (the "Offering") for aggregate gross proceeds of $23,029,900 (All figures are in Canadian dollars unless otherwise stated). A total of 4,370,000 units (the "Units") of the Company were sold pursuant to the Offering, including 570,000 Units issued as a result of the full exercise of the Underwriters' over-allotment option, at a price of $5.27 per Unit. The Offering was conducted by a syndicate of underwriters co-led by Beacon Securities Limited and Canaccord Genuity Corp. and including Haywood Securities Inc.
Each Unit consists of one common share (a "Common Share") in the capital of the Company and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a "Warrant") of the Company. Each Warrant entitles the holder thereof to acquire one Common Share at an exercise price of $6.85 per Common Share for a period of 24 months from the closing of the Offering.
The Company intends to use the majority of the net proceeds of the Offering to fund ongoing development at the Sunniva Canada Campus greenhouse facility in Okanagan Falls, British Columbia and the Sunniva California Campus greenhouse facility in Cathedral City, California. It is intended that the remaining net proceeds of the Offering will be used by the Company for working capital and general corporate purposes.
The Units issued under the Offering were offered by way of a short form prospectus dated October 4, 2018 (the "Prospectus") filed in the provinces of British Columbia, Alberta and Ontario and were offered in the United States to Qualified Institutional Buyers pursuant to exemptions from the registration requirements under rule 144A of the United States Securities Act of 1933, as amended, in a manner that does not require the Units to be registered in the United States. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
OAKVILLE, ON, Oct. 12, 2018 /CNW/ - Sheridan has adopted a new smoke-free policy, which will see all of its campuses become 100% smoke-free as of October 17, 2018.
As such, smoking any form of tobacco and/or cannabis, vaping and use of e-cigarettes and smokeless tobacco (commonly known as chewing tobacco) will not be permitted anywhere on Sheridan campuses as of October 17, 2018. The new policy accords with Ontario legislation which makes consumption of recreational cannabis in the workplace illegal. In accordance with applicable legislation and the Workplace Accommodation Policy, Sheridan will provide accommodation for the medical use of cannabis.
Sheridan has been working towards attaining smoke-free status since 2012, when we introduced designated smoking shelters at our Oakville and Brampton campuses. Our Hazel McCallion Campus in City of Mississauga has always been smoke-free, due to its location on City-owned lands and the need to comply with City by-laws.
The college had been working towards implementing our new Smoke Free Sheridan Policy in the Spring of 2019, however, the provincial government's recent announcement of its intent to allow the use of cannabis wherever tobacco smoking is permitted prompted us to move up our implementation date, to coincide with the legalization of recreational cannabis.
Sheridan is committed to promoting a healthy and safe working, living and learning environment for all of our community members. At the same time, we realize that the use of tobacco and related products is a personal one. For those members of our community who are interested in quitting or reducing their consumption, we are providing them with information on a variety of internal and external resources to assist in their journey. More details are provided at sharecleanair.sheridancollege.ca.
Sungrown BC Cannabis Producer Tantalus Labs Announces Network of Medical Cannabis Clinics and Absorption of Federal Excise Tax for Medical Patients
E-Commerce Cannabis Membership Program Tantalus Prime Introduces New Way to Register
VANCOUVER, Oct. 12, 2018 /CNW/ - British Columbia-based cannabis producer, Tantalus Labs, announced today that it has entered into new agreements with medical cannabis clinics across Canada, allowing for convenient access to Sungrown B.C. cannabis through e-commerce membership program, Tantalus Prime. In addition to online registration at Tantaluslabs.com, customers can now register in person at clinic locations across the country.
Further, the company will be absorbing the cost burden of Federal Excise Tax levied on Medical Cannabis, and as such the company's Medical Cannabis pricing will not change on October 17th.
With a consistent supply of highly reviewed cannabis, Tantalus Labs is accepting new ACMPR clients across Canada for Tantalus Prime. Online registration includes basic questions completed at TantalusLabs.com, which then automatically populates and submits paperwork on a client's behalf.
New for October, clients can now attend a medical consultation at a partner clinic to register with Tantalus Labs, free of charge. The following clinics have relationships with Tantalus Labs to provide a seamless registration to Tantalus Prime:
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
VANCOUVER, Oct. 12, 2018 /CNW/ - Village Farms International, Inc. ("Village Farms" or the "Company") (TSX: VFF) (OTCQX: VFFIF) announced today that it has completed its previously announced bought deal offering of 3,097,200 common shares (the "Offered Shares") in the capital of the Company at a price of $7.13 per Offered Share (the "Issue Price") for aggregate gross proceeds to the Company of $22,083,036 (the "Offering"). The Offering was conducted by a syndicate of underwriters led by Beacon Securities Limited, and including GMP Securities L.P. (collectively, the "Underwriters"). The Offering included 287,200 Offered Shares issued pursuant to a partial exercise of the Underwriters' over-allotment option.
The Company intends to use the net proceeds of the Offering for working capital purposes, which may include funding certain future capital needs of Pure Sunfarms Corp. as well as other growth opportunities that may arise in respect of the Company's business over time. Further details can be found in the Company's short form prospectus dated October 4, 2018, which is available on SEDAR at www.sedar.com.
Upon closing of the Offering, there were 47,619,338 issued and outstanding common shares of the Company.
The Offered Shares have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or any applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.